Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Randomized, double-blind, multicenter trial of hydrogen water for Parkinson's disease.

Yoritaka A, Ohtsuka C, Maeda T, Hirayama M, Abe T, Watanabe H, Saiki H, Oyama G, Fukae J, Shimo Y, Hatano T, Kawajiri S, Okuma Y, Machida Y, Miwa H, Suzuki C, Kazama A, Tomiyama M, Kihara T, Hirasawa M, Shimura H, Oda E, Ito M, Ohno K, Hattori N.

Mov Disord. 2018 Sep;33(9):1505-1507. doi: 10.1002/mds.27472. Epub 2018 Sep 12. No abstract available.

PMID:
30207619
2.

COQ2 variants in Parkinson's disease and multiple system atrophy.

Mikasa M, Kanai K, Li Y, Yoshino H, Mogushi K, Hayashida A, Ikeda A, Kawajiri S, Okuma Y, Kashihara K, Sato T, Kondo H, Funayama M, Nishioka K, Hattori N.

J Neural Transm (Vienna). 2018 Jun;125(6):937-944. doi: 10.1007/s00702-018-1885-1. Epub 2018 Apr 11.

PMID:
29644397
3.

Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics.

Yoritaka A, Abe T, Ohtsuka C, Maeda T, Hirayama M, Watanabe H, Saiki H, Oyama G, Fukae J, Shimo Y, Hatano T, Kawajiri S, Okuma Y, Machida Y, Miwa H, Suzuki C, Kazama A, Tomiyama M, Kihara T, Hirasawa M, Shimura H, Hattori N.

BMC Neurol. 2017 Feb 20;17(1):35. doi: 10.1186/s12883-017-0817-2. No abstract available.

4.

A Case of Painless Legs and Moving Toes Syndrome in Parkinson's Disease Responsive to Dopaminergic Therapy.

Kawajiri S, Hoshino Y, Nakamura R, Noda K, Tomizawa Y, Hattori N, Okuma Y.

Case Rep Neurol Med. 2016;2016:6829410. doi: 10.1155/2016/6829410. Epub 2016 Aug 28.

5.

Occipital lobe seizures and subcortical T2 and T2* hypointensity associated with nonketotic hyperglycemia: a case report.

Sasaki F, Kawajiri S, Nakajima S, Yamaguchi A, Tomizawa Y, Noda K, Hattori N, Okuma Y.

J Med Case Rep. 2016 Aug 12;10(1):228. doi: 10.1186/s13256-016-1010-8.

6.

A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics.

Yoritaka A, Abe T, Ohtsuka C, Maeda T, Hirayama M, Watanabe H, Saiki H, Oyama G, Fukae J, Shimo Y, Hatano T, Kawajiri S, Okuma Y, Machida Y, Miwa H, Suzuki C, Kazama A, Tomiyama M, Kihara T, Hirasawa M, Shimura H, Hattori N.

BMC Neurol. 2016 May 12;16:66. doi: 10.1186/s12883-016-0589-0. Erratum in: BMC Neurol. 2017 Feb 20;17 (1):35.

7.

Percutaneous Glycerol Rhizotomy for Trigeminal Neuralgia Using a Single-Plane, Flat Panel Detector Angiography System: Technical Note.

Arishima H, Kawajiri S, Arai H, Higashino Y, Kodera T, Kikuta K.

Neurol Med Chir (Tokyo). 2016 May 15;56(5):257-63. doi: 10.2176/nmc.tn.2015-0286. Epub 2016 Apr 4.

8.

Tumefactive demyelinating brain lesions with multiple closed-ring enhancement in the course of neuromyelitis optica.

Tomizawa Y, Nakamura R, Hoshino Y, Sasaki F, Nakajima S, Kawajiri S, Noda K, Takanashi M, Fujita N, Yokoyama K, Hattori N, Takahashi T, Okuma Y.

J Neurol Sci. 2016 Feb 15;361:49-51. doi: 10.1016/j.jns.2015.12.021. Epub 2015 Dec 14. No abstract available.

PMID:
26810516
9.

Diagnostic Utility of Splenial Lesions in a Case of Legionnaires' Disease due to Legionella pneumophila Serogroup 2.

Tomizawa Y, Hoshino Y, Sasaki F, Kurita N, Kawajiri S, Noda K, Hattori N, Amemura-Maekawa J, Kura F, Okuma Y.

Intern Med. 2015;54(23):3079-82. doi: 10.2169/internalmedicine.54.4872. Epub 2015 Dec 1.

10.

Delayed chorea after recovery from severe akinetic-rigid parkinsonism caused by extrapontine myelinolysis.

Noda K, Tosaka Y, Ishiguro Y, Kawajiri S, Tomizawa Y, Hattori N, Okuma Y.

J Neurol Sci. 2015 Nov 15;358(1-2):498-500. doi: 10.1016/j.jns.2015.09.021. Epub 2015 Sep 10. No abstract available.

PMID:
26384614
11.

Middle Cerebral Artery Occlusion Presenting as Upper Limb Monochorea.

Noda K, Nakajima S, Sasaki F, Ito Y, Kawajiri S, Tomizawa Y, Hattori N, Yamamoto T, Okuma Y.

J Stroke Cerebrovasc Dis. 2015 Oct;24(10):e291-3. doi: 10.1016/j.jstrokecerebrovasdis.2015.06.009. Epub 2015 Aug 17.

PMID:
26294216
12.

Pisa syndrome in progressive supranuclear palsy: A case report.

Noda K, Kawajiri S, Tomizawa Y, Hattori N, Okuma Y.

Parkinsonism Relat Disord. 2015 Sep;21(9):1115-6. doi: 10.1016/j.parkreldis.2015.07.005. Epub 2015 Jul 14. No abstract available.

PMID:
26195314
13.

Lymphomatoid Granulomatosis with Central Nervous System Involvement Successfully Treated with Cyclophosphamide, High-dose Cytarabine, Dexamethasone, Etoposide, and Rituximab (CHASER therapy) Followed by Brain Irradiation: A Case Study.

Fujimaki M, Kawajiri S, Ichikawa K, Tomizawa Y, Nakazato T, Noda K, Hattori N, Koike M, Okuma Y.

CNS Neurosci Ther. 2015 Jul;21(7):610-2. doi: 10.1111/cns.12414. No abstract available.

PMID:
26096049
14.

Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease.

Yoritaka A, Kawajiri S, Yamamoto Y, Nakahara T, Ando M, Hashimoto K, Nagase M, Saito Y, Hattori N.

Parkinsonism Relat Disord. 2015 Aug;21(8):911-6. doi: 10.1016/j.parkreldis.2015.05.022. Epub 2015 May 29.

PMID:
26054881
15.

Low dose of clonazepam is effective in the treatment of painless legs and moving toes syndrome: a case report.

Kawajiri S, Noda K, Ikeda A, Koinuma T, Tomizawa Y, Hattori N, Okuma Y.

Case Rep Neurol. 2015 Mar 21;7(1):59-62. doi: 10.1159/000380942. eCollection 2015 Jan-Apr.

16.

P150glued-associated disorders are caused by activation of intrinsic apoptotic pathway.

Ishikawa K, Saiki S, Furuya N, Yamada D, Imamichi Y, Li Y, Kawajiri S, Sasaki H, Koike M, Tsuboi Y, Hattori N.

PLoS One. 2014 Apr 10;9(4):e94645. doi: 10.1371/journal.pone.0094645. eCollection 2014.

17.

Mutations in Fis1 disrupt orderly disposal of defective mitochondria.

Shen Q, Yamano K, Head BP, Kawajiri S, Cheung JT, Wang C, Cho JH, Hattori N, Youle RJ, van der Bliek AM.

Mol Biol Cell. 2014 Jan;25(1):145-59. doi: 10.1091/mbc.E13-09-0525. Epub 2013 Nov 6.

18.

Mechanisms of mitochondrial fission and fusion.

van der Bliek AM, Shen Q, Kawajiri S.

Cold Spring Harb Perspect Biol. 2013 Jun 1;5(6). pii: a011072. doi: 10.1101/cshperspect.a011072. Review.

19.

Genetic mutations and functions of PINK1.

Kawajiri S, Saiki S, Sato S, Hattori N.

Trends Pharmacol Sci. 2011 Oct;32(10):573-80. doi: 10.1016/j.tips.2011.06.001. Epub 2011 Jul 23. Review.

PMID:
21784538
20.

Nano-porous layer on steel surface as lubricant carrier.

Utsunomiya H, Kawajiri S, Takahira N, Sakai T, Tanaka T.

J Nanosci Nanotechnol. 2011 Feb;11(2):1750-3.

PMID:
21456283
21.

Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition.

Saiki S, Sasazawa Y, Imamichi Y, Kawajiri S, Fujimaki T, Tanida I, Kobayashi H, Sato F, Sato S, Ishikawa K, Imoto M, Hattori N.

Autophagy. 2011 Feb;7(2):176-87. Epub 2011 Feb 1.

22.

Sum-frequency mixing of radiation from two extended-cavity laser diodes using a doubly resonant external cavity for laser cooling of trapped ytterbium ions.

Sugiyama K, Kawajiri S, Yabu N, Matsumoto K, Kitano M.

Appl Opt. 2010 Oct 10;49(29):5510-6. doi: 10.1364/AO.49.005510.

PMID:
20935696
23.

Zonisamide reduces cell death in SH-SY5Y cells via an anti-apoptotic effect and by upregulating MnSOD.

Kawajiri S, Machida Y, Saiki S, Sato S, Hattori N.

Neurosci Lett. 2010 Sep 6;481(2):88-91. doi: 10.1016/j.neulet.2010.06.058. Epub 2010 Jun 25.

PMID:
20600601
24.

PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy.

Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA, Sou YS, Saiki S, Kawajiri S, Sato F, Kimura M, Komatsu M, Hattori N, Tanaka K.

J Cell Biol. 2010 Apr 19;189(2):211-21. doi: 10.1083/jcb.200910140.

25.

PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy.

Kawajiri S, Saiki S, Sato S, Sato F, Hatano T, Eguchi H, Hattori N.

FEBS Lett. 2010 Mar 19;584(6):1073-9. doi: 10.1016/j.febslet.2010.02.016. Epub 2010 Feb 12.

26.

Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica.

Saiki S, Ueno Y, Moritani T, Sato T, Sekine T, Kawajiri S, Adachi S, Yokoyama K, Tomizawa Y, Motoi Y, Hattori N.

J Neurol Sci. 2009 Sep 15;284(1-2):217-9. doi: 10.1016/j.jns.2009.05.022. Epub 2009 Jun 3.

PMID:
19497587
27.

Automated segmentation of hepatic vessels in non-contrast X-ray CT images.

Kawajiri S, Zhou X, Zhang X, Hara T, Fujita H, Yokoyama R, Kondo H, Kanematsu M, Hoshi H.

Radiol Phys Technol. 2008 Jul;1(2):214-22. doi: 10.1007/s12194-008-0031-4. Epub 2008 Jul 1.

PMID:
20821150
28.

Segmental zoster paresis of limbs: report of three cases and review of literature.

Kawajiri S, Tani M, Noda K, Fujishima K, Hattori N, Okuma Y.

Neurologist. 2007 Sep;13(5):313-7.

PMID:
17848871
29.

Discovery of diaminobutane derivatives as Ca(2+)-permeable AMPA receptor antagonists.

Yoneda Y, Mimura T, Kawagoe K, Yasukouchi T, Tatematu T, Ito M, Saito M, Sugimura M, Kito F, Kawajiri S.

Bioorg Med Chem. 2002 May;10(5):1347-59.

PMID:
11886798
30.

Synthesis of diaminobutane derivatives as potent Ca(2+)-permeable AMPA receptor antagonists.

Yoneda Y, Kawajiri S, Sugimura M, Osanai K, Kito F, Ota E, Mimura T.

Bioorg Med Chem Lett. 2001 Oct 8;11(19):2663-6.

PMID:
11551773
31.

Synthesis of polyamine derivatives having non-hypotensive Ca2 +-permeable AMPA receptor antagonist activity.

Yoneda Y, Kawajiri S, Hasegawa A, Kito F, Katano S, Takano E, Mimura T.

Bioorg Med Chem Lett. 2001 May 21;11(10):1261-4.

PMID:
11392532
32.

Nefiracetam enhances acetylcholine outflow from the frontal cortex: in vivo microdialysis study in the rat.

Kawajiri S, Taniguchi K, Sakurai T, Yamasaki T.

J Neural Transm Gen Sect. 1994;98(1):15-22.

PMID:
7710737
33.

Multiple structural determinants of voltage-dependent magnesium block in recombinant NMDA receptors.

Kawajiri S, Dingledine R.

Neuropharmacology. 1993 Nov;32(11):1203-11.

PMID:
8107974
35.

Effect of ketanserin on pressor response to vasoactive substances in early phase of one-kidney, one clip renal artery stenosis in rats and rabbits.

Fujie M, Ichikawa S, Kogure M, Hatakeyama K, Kawajiri S, Murata K.

Jpn Circ J. 1986 Nov;50(11):1174-80.

PMID:
3546768
37.

Hydrolytic deactivation of kyotorphin by the rodent brain homogenates and sera.

Matsubayashi K, Kojima C, Kawajiri S, Ono K, Takegoshi T, Ueda H, Takagi H.

J Pharmacobiodyn. 1984 Jul;7(7):479-84.

PMID:
6541692
38.

[A comparison of the effects of baclofen and some other muscle relaxants on alpha-rigidity in rats].

Kawajiri S, Kojima H, Akashi A.

Nihon Yakurigaku Zasshi. 1984 Mar;83(3):263-8. Japanese.

PMID:
6724434
40.

[Conference: care of a patient with hepatic cancer treated with catheterization of the umbilical vein].

Arai Y, Eida K, Kawajiri S, Nakamura Y, Nishida K.

Kango Gijutsu. 1980 Jun;26(8):64-8. Japanese. No abstract available.

PMID:
6901824
41.
42.
43.

Analgesic action of cyclazocine: blocking nociceptive responses induced by intra-arterial bradykinin-injection and tooth pulp stimulation.

Satoh M, Kawajiri S, Yamamoto M, Foong FW, Masuda C.

Arch Int Pharmacodyn Ther. 1979 Oct;241(2):300-6.

PMID:
526083
44.

Bradykinin-induced flexor reflex of rat hind-limb for evaluating various analgesic drugs.

Satoh M, Kawajiri S, Shishido K, Yamamoto M, Takagi H.

J Pharm Pharmacol. 1979 Mar;31(3):184-6. No abstract available.

PMID:
34698
45.

Reversal by naloxone of adaptation of rats to noxious stimuli.

Satoh M, Kawajiri S, Yamamoto M, Makino H, Takagi H.

Life Sci. 1979 Feb 19;24(8):685-9. No abstract available.

PMID:
440016
46.

The particle size evaluation of parenteral suspensions of chloramphenicol and correlation of particle size to plasma levels.

Kitamori N, Kawajiri S, Matsuzawa T.

Chem Pharm Bull (Tokyo). 1976 Nov;24(11):2597-602. No abstract available.

PMID:
1017098

Supplemental Content

Loading ...
Support Center